Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection

Nature Medicine

Volumn 8, Issue 1, 2002, Pages 47-53

  Levine, Bruce L ^a,c   Bernstein, Wendy B ^b,d,e   Aronson, Naomi E ^d,e   Schlienger, Katia ^a,c   Cotte, Julio ^a,c   Perfetto, Steven ^c   Humphries, Mary J ^d   Ratto Kim, Silvia ^c   Birx, Deborah L ^b   Steffens, Carolyn ^f   Landay, Alan ^f   Carroll, Richard G ^a,c   June, Carl H ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^f RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CYTOKINE; KI 67 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ADULT; BLOOD COMPONENT REMOVAL; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; FEASIBILITY STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, CCR5; T-LYMPHOCYTES; TRANSPLANTATION, AUTOLOGOUS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036157376     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0102-47     Document Type: Article

References (42)

1. + T cell responses associated with control of viremia
2. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
3. Immune control of HIV-1 after early treatment of acute infection
4. + T lymphocytes in HIV-infected individuals following antiretroviral therapy
5. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
6. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes
7. Syngeneic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus (HIV) infection
8. Syngeneic adoptive transfer of anti-human immunodeficiency virus- 1 (HIV-1)-primed lymphocytes from a vaccinated HIV-seronegative individual to his HIV-1-infected identical twin
9. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients
10. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death
11. Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies
12. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells
13. + T cells in the absence of exogenous feeder cells
14. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation
15. + T cells
16. Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation
17. + T cells from HIV-1 infected donors following CD3/CD28 costimulation
18. + T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study
19. The safety and efficacy of zidovudine (AZT) in the treatment of patients with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial
20. T-cell dynamics of immunodeficiency
21. + cell numbers and clinical staging
22. T-cell division in human immunodeficiency virus (HIV-1) infection is mainly due to immune activation: A longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART)
23. + lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle
24. + T-cell regeneration in HIV-infected adults
25. In vivo migration and function of transferred HIV-1 -specific cytotoxic T cells
26. Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome
27. Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection
28. + T cells in human immunodeficiency virus-infected patients
29. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
30. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection
31. A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS
32. Identification of a reservoir for HIV-1 in patients on highly active anti-retroviral therapy
33. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
34. + T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
35. Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy
36. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
37. + lymphocytes
38. + T cell depletion in simian immunodeficlency virus-infected macaques
39. Control of SIV rebound through structured treatment interruptions during early infection
40. + T lymphocytes
41. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T-helper dysfunction in blood and lymph nodes following acute HIV-1 infection
42. Detection of T cell receptor circles (TRECs) as biomarkers for de novo T cell synthesis using a quantitative polymerase chain reaction-enzyme linked immunosorbent assay (PCR-ELISA)